January 16, 2025

Exercise Therapy as Candidate Anticancer Strategy

Lee Jones, PhD, Head of the Exercise Oncology Program at Memorial Sloan Kettering Cancer Center, shared findings from an early-phase clinical trial to determine the feasibility, safety, and tumor biol...

The ASCO Post

January 16, 2025

Study Questions Urokinase's Role in Minor Stroke Care

For minor stroke patients, urokinase showed no added benefit for 90-day outcomes but remained safe, TRUST trial reveals.

Conexiant

January 15, 2025

Bertagnolli to Exit NIH Director Role

NIH director, Dr. Monica M. Bertagnolli, is stepping down after launching major initiatives in women's health and long COVID research, indicating optimism for their continuation under new leadership.

Conexiant

January 15, 2025

Metformin Exposure Shows Non-Melanoma Skin Cancer Associations

In a study of over 12,000 cases, metformin exposure was associated with a reduced risk of both squamous and basal cell carcinomas.

Conexiant

January 15, 2025

CMR-PCWP Correlates with Heart Failure Biomarkers

In HFrEF patients, cardiovascular magnetic resonance-estimated pulmonary capillary wedge pressure "correlates with clinical and ultrasound markers of congestion," demonstrates potential as a non-invasive alternative to traditional pressure measurements.

Conexiant

January 14, 2025

Remnant Cholesterol as Biomarker for Endometriosis, Study

‘An increase of one unit in RC was linked to a 135% rise in the likelihood of developing endometriosis,’ positioning remnant cholesterol as a promising marker for risk assessment.

Conexiant

January 13, 2025

Heart Age vs. CVD Risk in Care

Explore how heart age and short-term cardiovascular disease risk differ in guiding preventive care.

Conexiant

January 13, 2025

HF Event Reduction with Ertugliflozin: VERTIS CV

Ertugliflozin significantly reduces heart failure events in patients with type 2 diabetes and atherosclerotic cardiovascular disease.

Conexiant

January 08, 2025

Blood Pressure Less Important After Age 90

"Our findings suggest that vascular risk factors are not risk factors for cerebrovascular pathologic changes at this age, medications have mitigated risks, or survival bias obscures associations."

Conexiant